[PRLD] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 12.79%
YoY- -34.47%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
Revenue 0 0 0 0 0 0 -
PBT -31,431 -27,718 -29,465 -21,300 -9,511 -5,399 42.18%
Tax -426 -1,397 -823 -282 0 0 -
NP -31,431 -26,321 -28,642 -21,300 -9,511 -5,399 42.18%
Tax Rate - - - - - - -
Total Cost 31,431 26,321 28,642 21,300 9,511 5,399 42.18%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
EPS -0.42 -0.55 -0.61 -0.47 -0.29 -3.43 -34.26%
EPS Diluted -0.42 -0.55 -0.61 -0.47 -0.29 -3.42 -34.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.